Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $4.31 Million - $4.74 Million
46,700 Added 125.54%
83,900 $8.47 Million
Q2 2023

Aug 14, 2023

BUY
$92.52 - $104.91 $786,420 - $891,735
8,500 Added 29.62%
37,200 $3.75 Million
Q1 2023

May 15, 2023

BUY
$80.03 - $92.81 $968,363 - $1.12 Million
12,100 Added 72.89%
28,700 $2.64 Million
Q4 2022

Feb 14, 2023

BUY
$75.55 - $92.52 $1.25 Million - $1.54 Million
16,600 New
16,600 $1.51 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.